Link Between Antidepressants and Birth Defect

September 29, 2009 by Lin Edwards weblog
Fluoxetine (Prozac). Image: Wikimedia Commons

( -- Researchers in Denmark have studied almost half a million Danish children and found a slightly higher rate of septal heart abnormalities in babies whose mothers took an SSRI antidepressant drug during early pregnancy, especially if they took more than one type.

The scientists, Lars Henning Pedersen and colleagues, from Aarhus University in Denmark, aimed to identify any relationship between taking selective serotonin reuptake inhibitors (SSRIs) during and birth defects.

SSRIs are the drugs most often prescribed for women suffering from depression, and in the U.S. around 13% of pregnant women take these common antidepressant drugs, and there has been a concern for some time that the drugs might affect the developing fetus.

The research, published last week in the medical journal BMJ, was a population cohort study of 493,113 children born in Denmark between 1996 and 2003. It looked at the incidence of birth defects, including , and prescription SSRIs taken by the women in the first trimester.

The study found the risks of taking SSRIs were generally low, and no association was found with birth defects except that the rate of septal heart defects was slightly elevated. Septal heart defects are abnormalities in the wall dividing the left and right ventricles in the heart.

The incidence of septal heart defects was 0.5% (2315 of 493,113) in unexposed babies, 0.9% (12 of 1370) in babies of mothers who took one SSRI, and 2.1% (4 of 193) in babies of mothers who took more than one type of SSRI. Sertraline (Zoloft) and citalopram (Celexa) were associated with a slightly higher incidence than fluoxetine (Prozac) and paroxetine (Paxil, Pexeva).

Research in the U.S. in 2005 found that Paxil taken during pregnancy was associated with a slightly greater risk or in the fetus, but later studies, including the Danish study, have not confirmed this.

Dr Pedersen said more research is needed to decide if any particular SSRI is safer than another, since the various studies have implicated different drugs. As Professor Chambers of the University of California in San Diego writes in an editorial accompanying the research paper, the risk of taking the is extremely low and must be counterbalanced by the very real risks of leaving serious undertreated.

More information:

in pregnancy and congenital malformations: population based cohort study, BMJ 2009;339:b3569, doi:10.1136/bmj.b35doi:10.1136/bmj.b3525#8226; Editorial: BMJ 2009;339:b3525, doi:10.1136/bmj.b3525

© 2009

Related Stories

Recommended for you

Some breastfeeding advice worth ditching: US task force

October 25, 2016

A review of scientific evidence on breastfeeding out Tuesday found that some long-held advice is worth ditching, including that babies should avoid pacifiers and moms should breastfeed exclusively in the first days after ...

Sleep loss tied to changes of the gut microbiota in humans

October 25, 2016

Results from a new clinical study conducted at Uppsala University suggest that curtailing sleep alters the abundance of bacterial gut species that have previously been linked to compromised human metabolic health. The new ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.